Ftse Mib
34.191,79
-0,48%
DAX
19.210,81
-0,17%
S&P 500
5.870,62
-1,32%
NASDAQ
18.680,12
-2,24%
Bitcoin
90.570,14
-0,53%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE AbbVie Inc (ABBV) AbbVie Inc (ABBV) Notizie

AbbVie Inc

ABBV
165,30
-4,33 (-2,55%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202414:15PRNUSAbbVie Awards 20 Individuals Living With Migraine To Support..
11/11/202414:30PRNUSAbbVie Provides Update on Phase 2 Results for Emraclidine in..
07/11/202414:00PRNUSAllergan Aesthetics Celebrates Annual BOTOX® Cosmetic..
04/11/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202420:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202411:55IHMARKETNEWSAmazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising..
31/10/202413:00GLOBEAbbVie and EvolveImmune Therapeutics Announce Collaboration..
31/10/202413:00PRNUSAbbVie and EvolveImmune Therapeutics Announce Collaboration..
30/10/202412:43EDGAR2Form 8-K - Current report
30/10/202412:38PRNUSAbbVie Reports Third-Quarter 2024 Financial Results
29/10/202413:00PRNUSSkinSpirit joins Allergan Aesthetics in Supporting Girls..
28/10/202413:00PRNUSAbbVie to Acquire Aliada Therapeutics, Strengthening Focus..
24/10/202417:30PRNUSAbbVie and Gedeon Richter Announce New Collaboration for the..
21/10/202414:00PRNCANeuf provinces approuvent le remboursement accéléré par le..
19/10/202401:44PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval..
17/10/202414:00PRNUSU.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for..
16/10/202414:00PRNUSAllergan Aesthetics to Present New Data at 2024 American..
04/10/202415:00PRNUSAllergan Aesthetics and Girls Inc. Celebrate Six Years and..
03/10/202422:07EDGAR2Form 8-K - Current report
02/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202415:00IHNWTransforming Alzheimer's Treatment: Innovative Combinations..
02/10/202414:00PRNUSAvailable Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to..
01/10/202414:00PRNUSAbbVie to Host Third-Quarter 2024 Earnings Conference Call
30/9/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202418:13PRNUSAbbVie Submits Biologics License Application to the FDA for..
26/9/202414:00PRNCAAbbVie et SpinUp encouragent l'innovation dans le secteur..
25/9/202413:00PRNUSNew Analysis Demonstrates the Efficacy of RINVOQ®..
24/9/202414:00PRNUSEmpowering Women Entrepreneurs: 2024 BOTOX®..
20/9/202413:32PRNUSAbbVie Receives Positive CHMP Opinion for Mirvetuximab..
11/9/202414:30PRNUSAllergan Aesthetics Launches BOTOX® Cosmetic..
10/9/202421:30EDGAR2Form 8-K - Current report
10/9/202413:00PRNCAHealth Canada Approves AbbVie's CONSTELLA® (linaclotide) for..
09/9/202415:00PRNUSAbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO..
06/9/202416:13PRNUSAbbVie Declares Quarterly Dividend
04/9/202414:00PRNCAAbbVie reçoit une recommandation favorable de la part de..
27/8/202414:15PRNUSAbbVie Awards Scholarships to 45 U.S. Students Living With..
27/8/202414:05PRNUSSkinMedica® Revolutionizes Skin Hydration with the..
19/8/202420:05PRNUSEuropean Commission Grants Second Indication Approval for..
15/8/202415:14PRNCAAbbVie annonce les premiers remboursements provinciaux, en..
15/8/202415:13PRNCAAbbVie Announces Ontario and Quebec are First Provinces to..
14/8/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202423:40EDGAR2Form 144 - Report of proposed sale of securities
07/8/202422:22EDGAR2Form 144 - Report of proposed sale of securities
07/8/202421:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202414:23PRNUSAbbVie Completes Acquisition of Cerevel Therapeutics
30/7/202414:00PRNUSAllergan Aesthetics Celebrates the Second Annual JUVÉDERM®..
30/7/202412:00IHMARKETNEWSToyota Reports Another Global Production Decline, Delta Sues..
28/7/202414:05GLOBEAlector Presents Baseline Characteristics for INVOKE-2 Phase..
26/7/202408:00PRNUSAbbVie Announces European Commission Approval of SKYRIZI®..
Apertura: 170,01 Min: 164,72 Max: 170,01
Chiusura: 169,63

La tua Cronologia

NYSE
ABBV
AbbVie
LSE
LAUU
Amdi Australia
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network